XTX Topco Ltd Takes $123,000 Position in Enhabit, Inc. (NYSE:EHAB)

XTX Topco Ltd acquired a new position in Enhabit, Inc. (NYSE:EHAB) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 15,555 shares of the company’s stock, valued at approximately $123,000.

A number of other hedge funds also recently made changes to their positions in EHAB. Zacks Investment Management acquired a new stake in shares of Enhabit in the 3rd quarter worth approximately $107,000. Jane Street Group LLC lifted its stake in Enhabit by 514.3% during the third quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock valued at $7,119,000 after buying an additional 754,395 shares in the last quarter. Systematic Financial Management LP boosted its stake in Enhabit by 12.2% in the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock worth $14,522,000 after purchasing an additional 199,235 shares during the period. Point72 DIFC Ltd acquired a new stake in shares of Enhabit in the third quarter worth $108,000. Finally, Needham Investment Management LLC grew its stake in Enhabit by 42.9% during the 3rd quarter. Needham Investment Management LLC now owns 50,000 shares of the company’s stock valued at $395,000 after acquiring an additional 15,000 shares in the last quarter.

Enhabit Stock Down 0.6 %

Shares of EHAB opened at $7.65 on Friday. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $11.74. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The firm has a market capitalization of $384.67 million, a P/E ratio of -3.30 and a beta of 1.89. The company has a 50-day simple moving average of $7.64 and a 200-day simple moving average of $8.27.

Enhabit (NYSE:EHAB) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same period last year, the firm earned $0.03 EPS. On average, equities research analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Insider Activity at Enhabit

In related news, Director Stuart M. Mcguigan purchased 15,000 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The shares were acquired at an average cost of $8.81 per share, with a total value of $132,150.00. Following the completion of the purchase, the director now directly owns 46,810 shares of the company’s stock, valued at $412,396.10. This trade represents a 47.15 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jeffrey Bolton bought 4,000 shares of the stock in a transaction dated Thursday, December 12th. The stock was purchased at an average cost of $8.69 per share, with a total value of $34,760.00. Following the completion of the purchase, the director now directly owns 98,144 shares in the company, valued at approximately $852,871.36. This trade represents a 4.25 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on EHAB shares. Jefferies Financial Group upgraded shares of Enhabit from a “hold” rating to a “buy” rating and boosted their price target for the company from $8.25 to $9.50 in a report on Monday, December 9th. Leerink Partners reissued a “market perform” rating and issued a $8.00 price target (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $8.75.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.